Lidocaine Hydrochloride Injection, Solution
Product Images NDC 71872-7361

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 71872-7361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7361.pdp (7361)

This is a description of a 1% Lidocaine HCI Injection, 50 mg/5 mL (10 mg/mL) single-dose syringe labeled for intravenous use for Ventricular Arrhythmia. Each mL contains lidocaine hydrochloride 10 mg, sodium chloride 7 mg. The medication and fluid path are sterile and non-pyrogenic. It is recommended to store between 20°C to 25°C with excursions permitted between 15°C to 30°C. The product is manufactured by Hospira, Inc. in Lake Forest, IL, USA. It is distributed by Medical Purchasing Solutions in Scottsdale, AZ.*

FDA Label Image

7361c.pdp (7361c)

FDA Label Image

7361m.pdp (7361m)

This is a description of a 1% Lidocaine HCI injection in a 5 mL single-dose syringe used for intravenous administration to treat ventricular arrhythmias. The medication contains 50 mg of Lidocaine HCI per 5 mL (10 mg/mL). The product is distributed by Hospira and intended for prescription use only. The location of the distributor is Lake Forest, IL 60045 in the USA. The medication is identified by the lot number and expiration date indicated on the packaging.*

FDA Label Image

Structural Formula Lidocaine Hydrochloride (Lidocaine Hydrochloride 01)

FDA Label Image

Logo (Lidocaine Hydrochloride 02)

This text is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.